Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ACAD | ACADIA PHARMACEUTICALS INC | Executive VP, Research & Dev | $1.52M | Feb 10, 2023 | ||
AVDL | AVADEL PHARMACEUTICALS PLC | Chief Medical Officer | Feb 14, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|